Article
Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
The Journal of antibiotics - 1 Dec 2013
Liu Li-guang, Zhu Yu-lin, Hu Li-fen, Cheng Jun, Ye Ying, Li Jia-bin
Abstract excerpt
No mutant-prevention concentration (MPC) with methicillin-resistant Staphylococcus epidermidis (MRSE) has been reported. The study aimed to evaluate the propensity of vancomycin individually and in combination to prevent MRSE from mutation. A total of 10 MRSE clinical isolates were included in the study. Susceptibility testing demonstrated that the susceptibility rates to vancomycin, rifampicin, levofloxacin and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.